This is a real-world medical entrance exam question, please give the true answer based on the question and selection. Topic name: All India exam, Subject name: Pathology
Which of the following is not a pharmacological propey of Repaglinide? 
Select and explain. 
A. Insulin Secretagogues, B. Reduces insulin resistance, C. Causes less hypoglycemia than sulfonylureas, D. Effectively reduced postprandial hyperglycemia
B: Reduces insulin resistance
Answer: B: Reduces insulin resistance 
Explanation: Repaglinide: the first member of the group, was approved for clinical use in 1998. These drugs modulate B cell insulin release by regula ng potassium efflux through the potassium channels. It should be taken just before each meal in doses of 0.25-4 mg; hypoglycemia is a risk if the meal is delayed or skipped or contains inadequate carbohydrate.